Evidence map›Paper›PMID 39946197›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Fragment-Based Approach for Hierarchical Nanotube Assembly of Small Molecules in Aqueous Phase.

Ayisha Zia, Meihui Yi, Zhiyu Liu, Fengbin Wang, Bing Xu

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ayisha ZiaDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Meihui YiDepartment of Chemistry, Brandeis University, 415 South Street, Waltham, MA, 02453, USA.ORCID https://orcid.org/0000-0002-1912-1043
Zhiyu LiuDepartment of Chemistry, Brandeis University, 415 South Street, Waltham, MA, 02453, USA.
Fengbin WangDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Bing XuDepartment of Chemistry, Brandeis University, 415 South Street, Waltham, MA, 02453, USA.ORCID https://orcid.org/0000-0002-4639-387X

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
Subcellular Enzyme-instructed self-assembly for molecular anticancer nanomedicinesR01CA142746 · NCI · BRANDEIS UNIVERSITY · PI Bing Xu · 2010 to 2026
$6.4M
Acquisition of cryo-electron microscopeS10OD024978 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DOKLAND, TERJE · 2020 to 2020
$2.0M
Understanding and using microbial conductive nanowiresR00GM138756 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WANG, FENGBIN · 2022 to 2024
$895k
Selectively eliminating residual human induced pluripotent stem cells (iPSCs) in cell mixtures for cell therapyR21EY036512 · NEI · BRANDEIS UNIVERSITY · PI XU, BING · 2024 to 2025
$375k
Testing in-situ formed nanofibers for inhibiting metastatic osteosarcoma (mOS) in murine modelsR03CA262920 · NCI · BRANDEIS UNIVERSITY · PI XU, BING · 2021 to 2022
$163k
Understanding and using microbial conductive nanowiresK99GM138756 · NIGMS · UNIVERSITY OF VIRGINIA · PI WANG, FENGBIN · 2021 to 2022
$130k
Foundation for the National Institutes of Health CA142746Foundation for the National Institutes of Health CA262920Foundation for the National Institutes of Health EY036512Foundation for the National Institutes of Health GM138756National Science Foundation DMR-2011846NCI NIH HHS 75N91019D00024NCI NIH HHS P30 CA013148NCI NIH HHS R01 CA142746NCI NIH HHS R03 CA262920NEI NIH HHS R21 EY036512NIGMS NIH HHS K99 GM138756NIGMS NIH HHS R00 GM138756NIH HHS S10 OD024978
6 · The paper itself

Abstract

A fragment-based approach has proven successful in drug design and protein assemblies, yet its potential for constructing biomaterials from simple organic building blocks remains underexplored, particularly for self-assembly in aqueous phases, where water disrupts intermolecular hydrogen bonding. To the best of our knowledge, this study introduces the first case of integrating fragments from self-assembling molecules to design a small organic molecule that forms novel hierarchical nanotubes with polymorphism. The molecule's compact design incorporates three structural motifs derived from known nanotube assemblies, enabling a hierarchical assembly process: individual molecules with two conformations form dimers, which organize into hexameric units. These hexamers further assemble into nanotubes comprising 2-, 5-, and 6-protofilament fibers. The nanofibers share a nearly identical asymmetric unit - a hexameric triangular plate - with similar axial and lateral interfaces. The lateral interface, involving interactions between phosphate groups and aromatic rings, exhibits plasticity, allowing slight rotational variations between adjacent units. This adaptability facilitates the formation of diverse nanofiber architectures, showcasing the flexibility of these systems in aqueous environments. By leveraging fragments of self-assembling molecules, this work demonstrates a straightforward strategy that combines conformational flexibility and self-assembling fragments to construct advanced supramolecular biomaterials from small organic building blocks in aqueous settings.

Indexed as

Fragment-based approachHierarchical self-assemblyPlasticity in assembly

Identifiers

PMID39946197
PMCPMC11975473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.